zotatifin
effector therapeutics
['eft226', 'zotatifin', 'effector therapeutics', '$eftr']
effector therapeutics reports positive interim results in zotatifin (eft226) phase 1/2 clinical trial at asco 2022 showing safety and tolerability, and initial signals of clinical activity $eftr 
Real-Time News, Market Data and Stock Quotes For Green Stocks @ https://t.co/70sW9CbveB